Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FONR logo FONR
Upturn stock ratingUpturn stock rating
FONR logo

Fonar Corporation (FONR)

Upturn stock ratingUpturn stock rating
$14.96
Last Close (24-hour delay)
Profit since last BUY4.84%
upturn advisory
Consider higher Upturn Star rating
BUY since 24 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: FONR (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $

1 Year Target Price $

Analysts Price Target For last 52 week
$Target price
Low$
Current$14.96
high$

Analysis of Past Performance

Type Stock
Historic Profit -3.09%
Avg. Invested days 32
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 93.69M USD
Price to earnings Ratio 11.9
1Y Target Price -
Price to earnings Ratio 11.9
1Y Target Price -
Volume (30-day avg) -
Beta 1
52 Weeks Range 12.00 - 18.68
Updated Date 06/29/2025
52 Weeks Range 12.00 - 18.68
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.25

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.19%
Operating Margin (TTM) 13.48%

Management Effectiveness

Return on Assets (TTM) 3.54%
Return on Equity (TTM) 6.91%

Valuation

Trailing PE 11.9
Forward PE -
Enterprise Value 78089814
Price to Sales(TTM) 0.91
Enterprise Value 78089814
Price to Sales(TTM) 0.91
Enterprise Value to Revenue 0.76
Enterprise Value to EBITDA 3.37
Shares Outstanding 6168460
Shares Floating 6030734
Shares Outstanding 6168460
Shares Floating 6030734
Percent Insiders 2.45
Percent Institutions 49.08

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Fonar Corporation

stock logo

Company Overview

overview logo History and Background

Fonar Corporation was founded in 1978 by Dr. Raymond Damadian, a pioneer in MRI technology. Fonar developed the first commercial MRI scanner and has focused on upright MRI systems since.

business area logo Core Business Areas

  • MRI Scanner Manufacturing: Designs, manufactures, and markets MRI scanners, primarily upright MRI systems.
  • MRI Scanner Service and Maintenance: Provides service, maintenance, and repair for its installed base of MRI scanners.
  • Management and Diagnostic Services: Manages diagnostic imaging facilities and provides diagnostic services.

leadership logo Leadership and Structure

Dr. Raymond Damadian is the Chairman and Founder. The company has a traditional corporate structure with functional departments.

Top Products and Market Share

overview logo Key Offerings

  • Upright MRI Scanners: Fonar's primary product is its line of Upright MRI scanners, allowing patients to be scanned in weight-bearing positions. Market share data is difficult to obtain precisely for upright MRI, but they are a niche player. Competitors include Siemens, GE Healthcare, and Philips who offer traditional MRI systems. Revenue from Upright MRI scanners makes up the majority of Fonar's revenue.
  • FONAR UPRIGHT MULTIPOSITIONAL MRI: The FONAR UPRIGHT MULTIPOSITIONAL MRI is a standup open MRI. Market share data is difficult to obtain precisely for upright MRI, but they are a niche player. Competitors include Siemens, GE Healthcare, and Philips who offer traditional MRI systems.

Market Dynamics

industry overview logo Industry Overview

The MRI market is driven by aging populations, increasing prevalence of chronic diseases, and technological advancements. Competition is intense, with major players investing heavily in R&D.

Positioning

Fonar occupies a niche position in the MRI market with its upright MRI technology. Its competitive advantage lies in its ability to provide weight-bearing imaging.

Total Addressable Market (TAM)

The global MRI market is projected to reach hundreds of billions of USD. Fonar's TAM is a fraction of that total, focused on the upright/open MRI segment.

Upturn SWOT Analysis

Strengths

  • Proprietary Upright MRI Technology
  • Established Brand in Niche Market
  • Strong Service and Maintenance Revenue
  • Founder Led

Weaknesses

  • Limited Market Share Compared to Major Players
  • High Reliance on Upright MRI Market
  • Smaller R&D Budget Compared to Competitors
  • Single Product Focus

Opportunities

  • Expanding into New Geographic Markets
  • Developing New Applications for Upright MRI
  • Partnerships with Healthcare Providers
  • Increasing Demand for Personalized Medicine

Threats

  • Intense Competition from Major MRI Manufacturers
  • Technological Advancements Rendering Upright MRI Obsolete
  • Changing Healthcare Regulations
  • Economic Downturn Impacting Capital Spending

Competitors and Market Share

competitor logo Key Competitors

  • SIEMENS (SIEGY)
  • GE Healthcare (GE)
  • Philips (PHG)

Competitive Landscape

Fonar's advantage is its upright MRI technology, but it faces significant competition from larger, more diversified players in the MRI market.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been moderate, driven primarily by sales and service of its Upright MRI systems.

Future Projections: Future projections are dependent on the company's ability to expand its market reach and innovate its product offerings. Please consult analyst estimates for future growth.

Recent Initiatives: Recent initiatives likely include efforts to expand distribution and improve the performance of its Upright MRI systems.

Summary

Fonar Corporation is a niche player in the MRI market with its unique upright MRI technology. While it has a strong brand and proprietary technology, it faces significant competition from larger companies. Its success depends on its ability to expand its market reach and continue innovating. The company should look out for technological changes that could impact the relevance of its upright MRI technology.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • Financial News Outlets
  • Market Research Reports
  • SEC Filings

Disclaimers:

The information provided is for informational purposes only and should not be construed as investment advice. Market share data is estimated and may not be precise.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Fonar Corporation

Exchange NASDAQ
Headquaters Melville, NY, United States
IPO Launch date 1987-01-01
Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D.
Sector Healthcare
Industry Diagnostics & Research
Full time employees 520
Full time employees 520

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.